Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-09 5:37 pm Purchase |
2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX |
Vivo Opportunity Fund Holdings, L.P. | 600,157 5.500% |
600,157 (New Position) |
Filing |